(Journal of Leukocyte Biology. 2001;70:601-609.)
© 2001
by Society for Leukocyte Biology
Differential regulation of transendothelial migration of THP-1 cells by ICAM-1/LFA-1 and VCAM-1/VLA-4
John A. Ronald,
Carmen V. Ionescu,
Kem A. Rogers and
Martin Sandig
Department of Anatomy and Cell Biology, The University of Western Ontario, London, Ontario, Canada
Correspondence: Martin Sandig, Department of Anatomy and Cell Biology, The University of Western Ontario, Medical Sciences Building, London, ON N6A 5C1, Canada. E-mail: msandig{at}julian.uwo.ca
 |
ABSTRACT
|
|---|
The adhesion molecules intercellular adhesion molecule 1 (ICAM-1) and
vascular cell adhesion molecule 1 (VCAM-1) expressed in atherogenic
lesions are thought to regulate monocyte diapedesis. To better
understand their specific roles we used function-blocking antibodies
and examined in a culture model the morphology, motility, and
diapedesis of THP-1 cells interacting with human coronary artery
endothelial cells. The number of motile THP-1 cells was reduced only
when VCAM-1 or both ICAM-1 and VCAM-1 were blocked. Blockade of ICAM-1
and VCAM-1, either separately or together, reduced to the same degree
the distance that THP-1 cells traveled. Diapedesis was reduced only
during the simultaneous blockade of both adhesion molecules. Blockade
of either ICAM-1 or VCAM-1 inhibited pseudopodia formation, but ICAM-1
blockade induced the formation of filopodia. We suggest that the
interactions of endothelial ICAM-1 and VCAM-1 with their ligands
differentially regulate distinct steps of diapedesis by modulating the
ratio of active and inactive forms of small GTPases such as Rho, Rac,
and Cdc42.
Key Words: adhesion molecules integrins endothelial cells microfilaments cell motility
 |
INTRODUCTION
|
|---|
Transendothelial migration (diapedesis) of leukocytes plays a key
role in the pathogenesis of inflammatory diseases, including the
development of atherosclerosis [1
]. In vivo studies have
shown that one of the earliest events in diet-induced atherosclerosis
is the migration of monocytes from the blood into the subendothelial
space [2
3
4
]. Although the exact mechanisms that control
the recruitment of monocytes in atherogenesis are not completely
understood, it is well documented that this process is mediated, in
part, by the interaction between endothelial adhesion molecules and
ligands present on monocytes [5
6
7
]. Intercellular
adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1
(VCAM-1) are two of the endothelial adhesion molecules that belong to
the immunoglobulin (Ig) superfamily of adhesion receptors believed to
mediate monocyte migration across the endothelium
[8
9
10
]. It is interesting that a significant
correlation has been found between the degree of macrophage
infiltration and endothelial ICAM-1 and VCAM-1 expression in
atherosclerotic lesions [11
].
Leukocyte extravasation is a process consisting of consecutive
adhesion-mediated events [10
, 12
13
14
].
During the first step, binding of selectins to carbohydrate ligands
triggers tethering of the leukocytes to the activated endothelium
followed by intermittent rolling along the vessel wall. After
selectin-mediated rolling, arrest and firm adhesion on endothelial
cells (ECs) depend on the activation of ß1 and ß2 integrins such as
very late antigen 4 (VLA-4) and lymphocyte function-associated antigen
1 (LFA-1), which bind to endothelial VCAM-1 and ICAM-1, respectively
[13
, 15
]. The specific activation factors
necessary are not yet completely understood but involve "inside-out
signaling" initiated by inflammatory cytokines or "outside-in
signaling" through binding of the integrins to their receptors
[16
17
18
19
]. It has been shown that the activation of
endothelium with tumor necrosis factor
, interleukin (IL)-1, and
IL-4 results in an increase of monocyte adhesion [20
]
caused by up-regulation in the expression of ICAM-1 and VCAM-1 in ECs
[21
, 22
].
Monocytes in their initial arrested state are spherical. Time-lapse
microcinematography demonstrates that, after the firm binding to ECs,
monocytes change their morphology (stretching) and then migrate in a
lateral direction over the apical surface of ECs [20
].
The regulatory mechanisms implicated in monocyte spreading along the
endothelium have not been fully characterized, but it is generally
known that a decrease in cortical tension and modulation of the
cytoskeleton, such as assembly and disassembly of F-actin, are
necessary to produce shape changes, protrusive forces, and polarized
morphology required for cell motility. Chemotactic movements of cells
involve the extension of pseudopodia and the formation of new adhesive
interactions at the leading front of the cell with controlled
retraction of the projections at the back of the cell, events that can
push the cell forward [23
]. The regulation of these
activities has recently been shown to involve the Rho family of small
GTPases, including Rho, Rac, and Cdc42. Each member of the Rho family
has different effects on the formation and morphology of the actin
cytoskeleton [24
, 25
]. In macrophages
interacting with extracellular matrix, RhoA induces the maintenance of
cortical cell tension and a round morphology, whereas Rac induces the
formation of lamellipodia and membrane ruffles, and Cdc42 regulates the
formation of filopodia [26
]. In addition, it has been
shown that Rho and Rac are required for macrophage migration, and
Cdc42, not being essential for cell locomotion, initiates cell
polarization and chemotactic gradient detection [27
].
Furthermore, Rho has been reported to activate ß1 and ß2 integrins
[28
].
Despite this information regarding cellular motility and locomotion on
solid surfaces, little is known about the mechanisms regulating
spreading and trafficking of monocytes along the apical surface of ECs.
It has been demonstrated that the spreading of endothelially bound
monocytes requires viable ECs and is in part an ICAM-1/VCAM-1-dependent
event [29
, 30
]. Lateral migration of
monocytes on top of ECs appears to be supported by VCAM-1/VLA-4
interaction [31
], whereas the migration of monocytes
through endothelium involves, in part, LFA-1 binding to ICAM-1 as well
as VLA-4 interaction with VCAM-1 [9
]. In addition,
recent studies suggest a cross talk between different integrins,
leading to modulation of leukocyte diapedesis [32
]. For
example, LFA-1 down-regulates VLA-4 activity and enhances leukocyte
motility on fibronectin [33
].
Despite this abundance of information regarding the mechanisms that
regulate leukocyte extravasation, the transendothelial migration
process itself is poorly understood, in part because the majority of
previous studies focused on quantifying leukocytes before and after
diapedesis, without analyzing their behavior during the actual
transmigration process. To overcome these limitations, we previously
developed a culture system that allows us to examine, by laser scanning
confocal microscopy (LSCM), changes in the morphology and distribution
of surface molecules during diapedesis. Using this system we
demonstrated that LFA-1 and F-actin are concentrated at sites of close
adhesion between THP-1 cells (human acute monocytic leukemia cells) and
ECs during all stages of diapedesis [34
,
35
]. For the present report, we used time-lapse
microcinematography and LSCM to investigate the effects of
function-blocking antibodies to ICAM-1 and VCAM-1 on different stages
of diapedesis, and we show that inhibiting ICAM-1/LFA-1 and
VCAM-1/VLA-4 interactions differentially affected monocyte morphology,
lateral migration, and transendothelial migration. In line with reports
implicating Rho, Rac, and Cdc42 in leukocyte locomotion, we suggest
that ICAM-1/LFA-1 and VCAM-1/VLA-4 interactions illicit signaling
mechanisms mediated by specific small GTPases.
 |
MATERIALS AND METHODS
|
|---|
Cells
Human coronary artery ECs (HCAECs) (Clonetics Corp., San Diego,
CA) were routinely cultured in EGM-2-MV purchased from
Clonetics Corp. This medium consists of endothelial basal medium 2
supplemented with 5% fetal bovine serum, human recombinant epidermal
growth factor, hydrocortisone, vascular endothelial growth factor,
human fibroblast growth factor-basic with heparin, Long R3-human
recombinant insulin-like growth factor 1, ascorbic acid, heparin,
gentamicyn 1000 (Clonetics Corp.), penicillin G (10,000 U/100 mL), and
streptomycin sulfate (10,000 µg/100 mL) (GIBCO/BRL, Burlington,
Canada). HCAECs in the fourth through ninth passages were used for
experiments. THP-1 cells (human acute monocytic leukemia cells), a gift
from M. Huff (The J. P. Robarts Research Institute, London, ON,
Canada), were routinely cultured in RPMI 1640 (GIBCO/BRL) supplemented
with 10% fetal bovine serum (Hyclone), 50 µM 2-mercapthoethanol
(Sigma Biosciences), penicillin G (10,000 U/100 mL), and streptomycin
sulfate (10,000 µg/100 mL) (GIBCO/BRL).
Human peripheral blood monocytes (PBMs) were obtained from healthy
adult donors and isolated by gradient centrifugation according to
manufacturers protocols using OptiPrep leukocyte isolation medium
(Accurate Chemicals, Westbury, NY). This isolation method yields
monocytes with an average purity of 8896%, and >95% viability
[36
]. PBMs (2.5x106 cells/mL) were
resuspended in EGM-2-MV before they were cocultured with
endothelial-cell monolayers.
Antibodies
Monoclonal mouse antihuman ICAM-1/CD54 IgG1 isotype, clone K562,
was obtained from Serotec Ltd., Kidlington, United Kingdom. Anti-ICAM-1
recognizes a functional epitope on ICAM-1, localized at the level of
the first Ig-like domain (NH terminal), specifically blocking the
interaction of ICAM-1 with LFA-1 on leukocytes. Anti-ICAM-1 inhibits
lymphocyte adhesion to ECs [37
]. Monoclonal mouse
anti-human VCAM-1, IgG1 isotype, clone P3C4 was obtained from Chemicon
International Inc., Temecula, CA. Previous studies confirmed that
monoclonal antibody P3C4 inhibits leukocyte adherence to bone marrow
stromal cells that express VCAM-1 [38
]. For control
experiments, human IgG pooled from normal serum was obtained from Sigma
Biosciences (catalog no. I4506). Fluorescein isothiocyanate
(FITC)-conjugated goat anti-mouse IgG was obtained from GIBCO/BRL, and
AlexaTM 488 goat anti-mouse IgG (H+L) from Molecular Probes, Eugene,
OR.
Transendothelial migration assay
Diapedesis was assayed as previously described
[35
]. Briefly, to provide a substrate for monocyte
transendothelial migration, sterile round glass coverslips (12 mm in
diameter) were coated with Matrigel (Becton Dickinson, Franklin Lakes,
NJ) at a dilution of 1:8. The Matrigel was air-dried at room
temperature for 1 h, followed by rehydration in Hanks balanced
salt solution (GIBCO/BRL). HCAECs were removed from culture dishes by
trypsinization with a solution containing 0.025% trypsin and 0.1 mM
EDTA in Hanks balanced salt solution lacking Ca2+ and
Mg2+ (GIBCO/BRL), resuspended in EGM-2-MV, and seeded onto
Matrigel at a concentration of about 2.52.8 x 105
cells/mL in a 200-µL drop of medium. This number of cells was
sufficient and necessary to obtain a confluent monolayer without
additional cell proliferation. Cells were allowed to attach and spread
in the drop on the Matrigel by incubating for 2 h at 37°C in a
humidified atmosphere containing 5% CO2. Coverslips were
then flooded with EGM-2-MV and incubated for at least 24 h before
the experiments. Confluent HCAEC monolayers on Matrigel were incubated
for 1218 h in EGM-2-MV containing 10 ng/mL of recombinant human
IL-1ß (Endogen, Cambridge, MA), which has been shown to
up-regulate the expression of ICAM-1 and VCAM-1 [39
],
and was washed with EGM-2-MV containing IL-1ß before addition of
leukocytes. To analyze diapedesis, THP-1 cells or PBMs were resuspended
in EGM-2-MV and added to IL-1ß-stimulated HCAECs at a ratio of
1
monocyte to 6 HCAECs [35
]. The cocultures were incubated
at 37°C for 30 min before fixation and immunostaining.
Time-lapse cinematography
To record cellular behavior and shape changes with an inverted
microscope, delta T dishes (Bioptechs, Inc., Butler, PA), each
containing a heatable glass coverslip as the bottom surface, were
coated with Matrigel. HCAEC monolayers were established and activated
with IL-1ß as previously described. After stimulation with IL-1ß,
the medium in cultures was replaced with sterile filtered 15 µM
Hanks HEPES-buffered medium containing IL-1ß. To analyze their
lateral migration on HCAECs, THP-1 cells were resuspended in
sterile-filtered 15 µM Hanks-HEPES-buffered medium and added to
IL-1ß-stimulated HCAECs at a ratio of
1 THP-1 cell to 3 HCAECs.
The cocultures were then placed on a heated stage (37°C; Bioptechs,
Inc.) mounted on a Leica DM-IRB microscope (Leica, Deerfield,
IL). Floating mineral oil on the top of the culture medium
prevented evaporation of the medium. Digital-phase contrast images of
cocultures magnified 400-fold were then taken every 14 s for 30
min using a computer-controlled digital camera (Sony, Tokyo,
Japan). Illumination of cultures by the microscope and timing
of the digital camera were controlled using Northern Eclipse and Cell
Time software (Empix Image, Inc., Mississauga, Canada). Images were
arranged sequentially using Adobe Premiere 5.0 software (Adobe Systems,
Inc., Mountain View, CA) to create a cinematization of THP-1
monocytes interacting with HCAEC monolayers.
Quantification of lateral migration
To analyze lateral migration of THP-1 cells along the apical
surface of HCAECs, monolayer plots of the positions of THP-1 cells on
top of the underlying endothelium within the last frame of the
cinematization were made. Individual cells were then visualized
throughout the entire length of the cinematization, and their lateral
movement with respect to the underlying endothelium was recorded.
Lateral migration was assessed as occurring only if the nucleus of a
spread THP-1 cell or the center of a round THP-1 cell moved relative to
the underlying endothelium. Endothelial monolayer shifting, which could
result in the movement of THP-1 cells within the frame of reference,
was not taken as evidence of lateral migration. Results are expressed
as mean percentages of control values ± SE. Two
groups were compared by Students t test, and differences
at P < 0.05 were considered to be significant. To
record the distance that individual THP-1 cells move in relation to the
underlying endothelium, a stage micrometer was photographed using the
same magnification as that during the recording of cocultures. This
image was transferred to Adobe Premiere 5.0, and a ruler was
constructed from the image on the computer screen. The ruler was then
used on the computer screen images of the cinematizations to determine
the distance migrated along the endothelium. The distances of only
those THP-1 cells that remained in every frame throughout the
cinematization were recorded. Results are expressed as mean percentages
of control values ± SE of two separate experiments
done in triplicate. Data from a minimum of 40 cells per treatment were
collected. Two groups were compared by a nonparametric signed rank test
according to Wilcoxon [40], and differences at P <
0.05 were considered to be significant.
Use of function-blocking antibodies
To examine the effect of function-blocking antibodies on
monocyte motility and diapedesis, confluent monolayers of
IL-1ß-stimulated HCAECs on Matrigel were preincubated for 30 min with
EGM-2-MV containing 10 or 20 µg/mL of monoclonal mouse anti-human
ICAM-1 or 5, 10, or 100 µg/mL of monoclonal mouse anti-human VCAM-1,
before addition of THP-1 cells or PBMs. EC monolayers were then washed
with EGM-2-MV containing 10 ng/mL of IL-1ß except in experiments
involving video microscopy, in which recording took place in the
presence of function-blocking antibodies. The diapedesis assays were
performed as described above. In control experiments, HCAECs were
incubated with an equivalent volume of medium lacking antibodies or
containing 10 µg/mL of an unrelated isotype-matched control IgG.
Immunofluorescence labeling
Confluent HCAEC monolayers were fixed at room temperature for 10
min in 2% paraformaldehyde in phosphate-buffered saline (PBS).
Cultures were washed three times for 5 min in PBS and then
labeled for F-actin, DNA, and either ICAM-1 or VCAM-1 as follows:
cultures were incubated for 1 h at room temperature with
monoclonal mouse anti-human ICAM-1/CD54 clone K562 or with monoclonal
mouse anti-human VCAM-1 clone P3C4 at a dilution of 1:50 in PBS
containing 1% bovine serum albumin (BSA). Either of two different
fluorescently labeled secondary antibodies was used: FITC-conjugated
goat anti-mouse IgG (GIBCO/BRL) or AlexaTM 488 goat anti mouse IgG
(H+L) at a dilution of 1:300 in PBS containing 1% BSA. To visualize
F-actin-fixed HCAECs were permeabilized for 5 min with a buffer
containing 15 mM Tris, 120 mM NaCl, 25 mM KCl, 2 mM EDTA, 2 mM EGTA,
and 0.5% Triton X-100 at pH 7.4 and were incubated for an hour at room
temperature with either Texas Red-X phalloidin or with fluorescein
phalloidin, at a dilution of 1:10 in PBS containing 1% BSA. Control
monolayers were treated by omitting the primary antibodies from the
procedures. Between incubation periods, cultures were rinsed three
times for 5 min in PBS. Nuclei were labeled for 5 min with
Bisbenzimide (Hoechst 33342; Sigma) at a concentration of 10 nM in PBS
before mounting. To prevent the contact of cells with the microscope
slide, coverslips were placed on plastic spacers and mounted in
Vectashield (Vector Laboratories, Burlington, Canada). Coverslips were
then sealed with nail enamel.
Microscopic analysis
Samples were analyzed by fluorescence microscopy, using a Zeiss
Axiophot microscope equipped with epifluorescence and appropriate
filters, or by LSCM. Serial optical sections (0.81.0 µm thick) of
the samples were obtained with a Zeiss LSM 410 laser scan confocal
microscope (Carl Zeiss Canada Ltd., Toronto, Canada). The following
excitation wavelengths were used: 488 nm for FITC, 568 nm for Texas
Red, and 351364 nm for Hoechst dye. The dichroic beam splitters
(DBSP) used were DBSP 488/568 for excitation by 488 and 568 nm, and FT
395 for excitation by UV.
Quantification of diapedesis
To score monocytes at different stages of diapedesis, their
positions with regard to ECs were evaluated on samples double labeled
for F-actin and DNA [35
]. Monocytes were divided into
the following categories: a) round on top (spherical monocytes on top
of ECs with stress fibers located underneath the monocytes); b) spread
on top (monocytes located on the apical surface of ECs but showing
cytoplasmic protrusions); c) transmigrating (monocytes located
partially above and partially below EC stress fibers; d) underneath
(monocytes located underneath ECs [stress fibers were situated above
the monocyte]). Each experiment was done in triplicate and repeated at
least twice. Unless otherwise specified, 300 cells were scored for each
coverslip. Results are expressed as mean percentages of control
values ± SE. Groups were compared by performing a
one-way analysis of variance followed by Scheffes multiple-contrast
test, and differences at P < 0.05 were considered to
be significant.
 |
RESULTS
|
|---|
Blockade of ICAM-1 or VCAM-1 differentially affects monocyte
morphology
Our previous studies showed that during diapedesis the
distribution of LFA-1 and F-actin in THP-1 cells and catenins in the
endothelium in our culture model is similar to that in PBMs migrating
through rat aortas in situ, indicating that THP-1 cells are a good
model for analyzing molecular events during monocyte diapedesis.
Because spreading of THP-1 cells on the apical surface is a component
of diapedesis and depends on the presence of ICAM-1 and VCAM-1, we
first ascertained by immunocytochemistry that, on Matrigel, endothelial
monolayers express both adhesion molecules after stimulation with
IL-1ß (data not shown). The effects of endothelial treatment with
anti-ICAM-1 and anti-VCAM-1 were analyzed and quantified with respect
to monocyte spreading. Phase-contrast images revealed that THP-1 cells
normally extend long pseudopodia and lamellipodia once they are
spread on top of the endothelium (Fig. 1a
). ICAM-1 and VCAM-1 blockade produced THP-1 cells that remained
somewhat round (Fig. 1b
1c)
, but ICAM-1 blockade alone induced the
formation of filopodia by THP-1 cells (Fig. 1b)
. Blockade of both
ICAM-1 and VCAM-1 simultaneously resulted in THP-1 cells with a similar
round morphology to those under VCAM-1 blockade (Fig. 1d)
.

View larger version (147K):
[in this window]
[in a new window]
|
Figure 1. Effects of function blocking antibodies to ICAM-1 and VCAM-1 on the
morphology of THP-1 cells adhered to HCAEC monolayers. THP-1 cells were
cultured for 30 min with stimulated HCAECs that were untreated (a) or
pretreated with anti-ICAM-1 (b), anti-VCAM-1 (c), or both anti-ICAM-1
and anti-VCAM-1 simultaneously (d). Phase contrast micrographs of
cocultures revealed that THP-1 cells formed prominent long pseudopodia
and lamellipodia (arrows in panel a). ICAM-1 or VCAM-1 blockade (b, c)
resulted in THP-1 cells remaining more compact (arrowheads) but with
slender filopodia extensions (arrows in b) in ICAM-1 blockade. The
extension of pseudopodia was lacking in cocultures with HCAECs that
were pretreated with both antibodies (d). Scale bar, 10µm.
|
|
To examine the changes in morphology in more detail and to ascertain
that PBMs behave similarly to THP-1 cells, we labeled cocultures for
F-actin and analyzed them using LSCM. On control endothelia and those
pretreated with control IgG, THP-1 cells and PBMs formed lamellipodia
and pseudopodia, whereas pseudopodia formation was largely reduced on
endothelia pretreated with anti-ICAM-1 or anti-VCAM-1. Prominent
extensions of filopodia were seen when ICAM-1/LFA-1 interactions were
blocked (Fig. 2c
, d
). These filopodia appeared as thin protrusions and were often
tapered with a broad base and thinner tip pointing outward. They had
variable lengths (sometimes longer than 10 µm) and contained high
concentrations of F-actin. Anti-VCAM-1 pretreatment inhibited the
formation of pseudopodia or lamellipodia (Fig. 2d
2h)
. However, in
contrast to the effects of pretreatment with anti-ICAM-1, monocytes
interacting with anti-VCAM-1 pretreated HCAECs did not extend filopodia
but remained rather compact (Fig. 2d
2h)
. Pretreatment with control IgG
did not appear to affect the morphology of THP-1 cells or PBMs, when
they interacted with HCAECs (Fig. 2b)
. When we scored THP-1 cells
according to the shape of their surface extensions, we found a
significant fourfold reduction in the percentage of cells with long
pseudopodia or lamellipodia after either anti-ICAM-1 or anti-VCAM-1
pretreatment of HCAECs (Fig. 3
). After VCAM-1 blockade, a twofold increase in the number of THP-1
cells that remained rather compact was observed as compared with THP-1
cells interacting with untreated ECs. These cells, in addition, did not
form any filopodia. In contrast to the effect of anti-VCAM-1,
anti-ICAM-1 pretreatment of HCAECs resulted in a dramatic 10-fold
increase in the number of THP-cells that formed prominent filopodia
(Fig. 3) .

View larger version (93K):
[in this window]
[in a new window]
|
Figure 2. Effects of ICAM-1 (c, g) or VCAM-1 (d, h) blockade on F-actin
distribution in THP-1 cells (ad) and PBMs (eh) adhered to
HCAEC monolayers. Monocytes were cultured for 30 min with stimulated
HCAECs that were untreated (a, e) or pretreated with an unrelated
isotype-matched control antibody (b, f), anti-ICAM-1 (c, g), or anti
VCAM-1 (d, h). Cultures were fixed, stained with phalloidin, and
examined by confocal microscopy. Monocytes spreading on control
cultures (a, e, b, f) formed F-actin-rich lamellipodia (arrowheads in
panels a and e) and pseudopodia (open arrows in panels b and f). In
contrast, monocytes extended prominent F-actin rich filopodia (solid
arrows in panels c and g) on the surface of anti-ICAM-1-pretreated
HCAECs. Anti-VCAM-1 pretreatment of HCAECs inhibited the formation of
pseudopodia and filopodia (d, h). Scale bar, 10µm.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Figure 3. Quantification of the morphologies of THP-1 cells after the blockade of
ICAM-1 or VCAM-1 on HCAECs. THP-1 cells were cocultured for 30 min with
untreated (black bars), anti-ICAM-1-pretreated (hatched bars), or
anti-VCAM-1 pretreated (white bars) HCAEC monolayers and scored
according to their morphology. ICAM-1 and VCAM-1 blockade resulted in a
fourfold reduction in the percentage of THP-1 cells extending normal
pseudopodia. A twofold increase in the percentages of cells with
compact morphology was observed after VCAM-1 blockade. In addition,
ICAM-1 blockade resulted in a 10-fold increase in the percentage of
cells that formed filopodia. Results are expressed as the mean
percentage ± SD of three separate experiments done in
triplicate. *Significantly different compared with controls
(P<0.05).
|
|
ICAM-1 and VCAM-1 differentially regulate the migration of THP-1
cells along HCAECs
After their adhesion and spreading on the apical surface of
ECs, monocytes migrate along the endothelium [20
].
Because pretreatment of HCAECs with antibodies to ICAM-1 or VCAM-1
greatly affected the ability of THP-1 cells to form normal pseudopodia
or lamellipodia, it was of interest to examine how this would affect
the lateral migration of THP-1 cells in our assay system (Fig. 4
). Using time-lapse video microscopy, we counted the number of
cells that translocated along the endothelial surface over 30 min. In
control cultures, 84% of monocytes migrated laterally. ICAM-1 blockade
had no effect on the ability of THP-1 cells to translocate on the
endothelium. In contrast, blockade of VCAM-1 inhibited by 30% the
ability of THP-1 cells to migrate laterally (Fig. 4a) . These results
suggest that VCAM-1/VLA-4 interactions alone are involved in the
lateral migration of THP-1 cells across the apical surface of ECs.
However, the simultaneous blockade of both ICAM-1 and VCAM-1 resulted
in a 55% decrease in the percentage of monocytes translocating on the
EC surface suggesting that ICAM-1/LFA-1 interactions are also involved
in this process (Fig. 4a)
. It is conceivable that ICAM-1 and/or VCAM-1
blockade differentially affect the distance that THP-1 cells travel
along the EC surface over a 30-min period. We therefore used the movies
produced to measure the distances traveled under various conditions
(Fig. 4b) . In control cultures, THP-1 cells translocated on average a
distance of 33 µm. Blockade of ICAM-1, VCAM-1, and both adhesion
molecules together reduced, to the same degree, the distance an
individual THP-1 cell traveled. Compared with the control, an
15-µm decrease or 40% reduction in the distance traveled was
recorded for all treatments (Fig. 4b)
. This suggests that ICAM-1 and
VCAM-1 might affect the same pathway that is used to maintain the
migration of monocytes along HCAECs.

View larger version (17K):
[in this window]
[in a new window]
|
Figure 4. Effects of ICAM-1 and VCAM-1 blockade on THP-1 cell migration along
HCAECs. THP-1 cells were cocultured with HCAEC monolayers pretreated
with anti-ICAM-1, anti-VCAM-1, or both anti-ICAM-1 and anti-VCAM-1
together. THP-1 cells were recorded for 30 min by time-lapse video
microscopy, and the number of translocating cells (a) and the distances
traveled (b) were determined. VCAM-1 blockade resulted in a 30%
decrease in the percentage of THP-1 cells migrating along HCAECs
compared with control cells, whereas simultaneous blockade of ICAM-1
and VCAM-1 inhibited lateral migration by 55%. No significant
effect was seen when ICAM-1 was blocked. The blockade of ICAM-1,
VCAM-1, or both molecules together reduced the distance that cells
traveled by approximately 40% (b). Results are expressed as mean
percentage ± SE of two separate experiments performed
in triplicate. *, significantly different compared with controls
(P<0.05).
|
|
ICAM-1 and VCAM-1 together regulate diapedesis of THP-1 cells
Because it was apparent that ICAM-1/LFA-1 and VCAM-1/VLA-4
interactions regulated the trafficking of monocytes along the
endothelial surface, we questioned to what extent these interactions
were involved in the trafficking of monocytes through the endothelium.
To evaluate the effects of function-blocking antibodies on diapedesis,
we used LSCM after labeling for F-actin [35
]. The
process of diapedesis can be divided into four recognizable stages
based on the location and morphology of the monocytes, as illustrated
in Figure 5
. These four categories are then used to quantify diapedesis during
a period of 30 min. THP-1 cells with a spherical morphology and with
HCAEC stress fibers present in optical sections below the plane of the
THP-1 cells (Fig. 5A III
, solid arrow) were called "round on top."
THP-1 cells that had acquired a flattened morphology and extended
pseudopodia (Fig. 5B
5II
, open arrow) on the EC surface and with
endothelial stress fibers present in optical sections below the plane
of the THP-1 cells (Fig. 5B III , solid arrow) were categorized as
being "spread on top" of the endothelial monolayer.
"Transmigrating" THP-1 cells (Fig. 5C 5I
III) were identified by
having three morphologically distinct regions: a spherical part
situated above the endothelial monolayer (Fig. 5C
5I)
; a spread part
underneath the endothelial monolayer (Fig. 5C III
), and a narrow
circular transmigration passage between these two (Fig. 5C
5II
,
arrowhead), through which the THP-1 cell nucleus translocates during
diapedesis. In most of the cases, the transmigration passage was
located at the contact region between two or more adjacent ECs. THP-1
cells that were located completely "underneath" the endothelium
(Fig. 5D 5I
III) had several pseudopodia (open arrow in Fig. 5D III )
and were identified by the presence of intact inter-EC junctions or
endothelial microfilament bundles (solid arrow in Fig. 5D
5I
) in
optical planes above the THP-1 cells. In Figure 6
, the numbers of transmigrating THP-1 cells and monocytes are
expressed as the summed data of the monocytes scored as transmigrating
and those underneath the endothelium (i.e., those that had
transmigrated). No significant decrease in the percentage of
transmigrating THP-1 cells was noted after either VCAM-1 or ICAM-1
blockade (Fig. 6a)
, which suggests that neither ICAM-1 nor VCAM-1
alone are involved in the transendothelial migration of monocytes.
However, the blockade of both ICAM-1 and VCAM-1 significantly reduced
the percentage of transmigrating monocytes, by 45% (Fig. 6a)
.
Therefore, it appears that both VCAM-1/VLA-4 and ICAM-1/LFA-1
interactions in concert regulate monocyte transendothelial migration.
Similarly, preliminary results indicated that diapedesis of PBMs is
also affected by antibodies to both adhesion molecules (Fig. 6c)
,
whereas pretreatment of HCAEC monolayers with an isotype-matched
control IgG had no effect on THP-1 cell diapedesis (Fig. 6b)
.

View larger version (66K):
[in this window]
[in a new window]
|
Figure 5. Morphological changes during THP-1 cell diapedesis. Optical sections
obtained by LSCM illustrate the four stages of monocyte (M) diapedesis
observable in HCAEC cocultures. THP-1 cells were cocultured for 30 min
with IL-1ß-stimulated HCAECs, fixed, and stained for F-actin. In
series A, cells were, in addition, labeled for LFA-1 to identify
monocytes, whereas in series B, cultures were labeled for ICAM-1 to
demonstrate the EC surface. The levels at which each optical section
was taken are indicated in the illustrations at left. The location of
the monocyte with respect to endothelium was determined by judging its
location relative to endothelial nuclei and/or microfilament bundles
(solid arrows in panels A, III; B, III; C, III; and D, I). Note that
monocytes were seen to either spread on top (B, II) or underneath (C,
III; D, III) the endothelium by extending pseudopodia (open arrows).
Transmigrating cells contained an F-actin-lined circular transmigration
passage at the level of the endothelium (arrowhead in panel C, II).
Nuclei are labeled blue with Hoechst dye. Scale bars,
10µm.
|
|

View larger version (19K):
[in this window]
[in a new window]
|
Figure 6. Effects of function-blocking antibodies to ICAM-1 or VCAM-1 on monocyte
diapedesis through HCAEC monolayers. THP-1 cells (a, b) or PBMs (c)
were cocultured with HCAEC monolayers pretreated with anti-ICAM-1 (a),
anti VCAM-1 (a), both antibodies together (a, c), or an unrelated
isotype-matched control IgG (b). The numbers of transmigrating or
transmigrated (i.e., underneath) monocytes with a morphology as
illustrated in Figure 5C
and 5D
, respectively, were scored at different
time points and are expressed as percentages of control values.
Blockade of either ICAM-1 or VCAM-1 alone had no significant effect on
the percentage of monocyte diapedesis. In contrast, the simultaneous
blockade of ICAM-1 and VCAM-1 significantly reduced the percentage of
transmigrating monocytes by 45%. In panels a and b, results are
expressed as mean percentages ± SE of three separate
experiments performed in triplicate. Panel c represents data from one
experiment performed in triplicate. *, Significantly different compared
with controls (P<0.05).
|
|
 |
DISCUSSION
|
|---|
A considerable number of studies have explored the mechanisms
responsible for mediating monocyte diapedesis. In the last decade it
became clear that endothelial ICAM-1 and VCAM-1 interactions with their
monocytic counter receptors LFA-1 and VLA-4, respectively, are involved
in mediating diapedesis [6
, 9
,
15
]. In the present study we used a novel culture model
of diapedesis combined with time-lapse video microscopy and confocal
microscopy to further dissect the specific roles of LFA-1/ICAM-1 and
VLA-4/VCAM-1 interactions with function-blocking antibodies to ICAM-1
and VCAM-1. Most of our experiments were performed with THP-1 cells.
These cells have characteristics of monocytes and transmigrate through
cultured endothelial monolayers [35
] in a manner similar
to PBMs in situ [34
], and, in contrast to PBMs, they can
be genetically engineered to dissect molecular events during
diapedesis.
Monocyte shape changes
Previous studies have referred to monocytes that are spread on ECs
as "stretched monocytes" [29
, 30
]. Our
study demonstrates that most of the THP-1 cells and PBMs that are
spread on the apical surface of IL-1ß-stimulated HCAECs extended
lamellipodia or long pseudopodia. It is not surprising that
concentrations of F-actin are observed at the leading front of
pseudopodia or lamellipodia, suggesting that these monocytes are in a
motile state at the time of fixation. Using function-blocking
antibodies to ICAM-1 and VCAM-1, we present evidence that the formation
of pseudopodia and lamellipodia is differentially regulated by
endothelial ICAM-1 and VCAM-1. The antibodies used have previously been
shown to specifically block ICAM-1/LFA-1 interactions and
VCAM-1-mediated binding of leukocytes to bone marrow stromal cells
[37
]. We obtained similar results with antibody
concentrations up to 100µg/mL, indicating that the 10-µg/mL
concentration used throughout the study was sufficient to saturate the
appropriate interaction sites. The fact that these antibodies have
different effects on the shape and motility of monocytes indicates that
these effects are not caused by nonspecific interactions. In addition,
treatment with isotype-matched control IgG did not affect monocyte
morphology, indicating that our results are unlikely to be caused by Fc
receptor blockade or activation.
The spreading of monocytes on human umbilical vein ECs has previously
been reported to be mediated by ICAM-1 but to be independent of
VCAM-1/VLA-4 interactions [29
, 30
]. Our
finding that VCAM-1 blockade prevented the formation of pseudopodia and
lamellipodia by monocytes contradicts this report and suggests that
both ICAM-1/LFA-1 and VCAM-1/VLA-4 interactions play a role in a
monocytes ability to form normal pseudopodia and lamellipodia on
HCAEC monolayers.
Recent studies suggest cross talk between different integrins, leading
to a modulation of leukocyte diapedesis [32
]. Our
results show that the blockade of ICAM-1, VCAM-1 or both adhesion
molecules together increases the number of monocytes that maintain a
round morphology. Therefore, it is possible that downstream members of
the Rho family of GTP-binding proteins [24
,
41
] are regulated by both ICAM-1/LFA-1 and VCAM-1/VLA-4
interactions. Rho inhibition has been shown to reduce the cortical
tension in macrophages and cause cell spreading [26
]. We
suggest that both ICAM-1/LFA-1 and VCAM-1/VLA-4 interactions are
required to deactivate Rho, thereby decreasing cortical tension and
allowing monocytes to spread on top of the endothelium.
The observation that ICAM-1 but not VCAM-1 blockade resulted in the
extension of filopodia by monocytes suggests a specific response
linking ICAM-1/LFA-1 interactions with downstream regulation of Cdc42.
Injection of active Cdc42 has been shown to induce the formation of
filopodia in macrophages [26
]. It is conceivable that
VCAM-1 might be responsible for the induction of filopodia formation
through the activation of Cdc42 but that this formation is tightly
regulated by ICAM-1. ICAM-1 could possibly inhibit Cdc42 so that
filopodia are not normally formed when monocytes interact with the
apical surface of the endothelium. In an alternative scenario, VCAM-1
could promote the activation of Cdc42 and ICAM-1 the activation of Rac,
resulting in the formation of pseudopodia and lamellipodia. The role of
Rac in lamellipodia formation has been shown in macrophages after
microinjection with active Rac [26
]. Because Rho may be
regulated by ICAM-1, an increased cortical tension might also inhibit
the formation of normal pseudopodia when VCAM-1 and ICAM-1 are blocked.
Thus the ratios of active and inactive forms of Rho, Rac, and Cdc42
determine the proper cytoskeletal rearrangements needed to produce
functional lamellipodia and pseudopodia. The absence of either
ICAM-1/LFA-1 or VCAM-1/VLA-4 interactions disrupts these ratios and
affects monocyte morphology.
Lateral migration of monocytes
The mechanisms by which a leukocyte moves along a cellular surface
are poorly understood, but they appear to depend on signaling events
that result in changes in cytoskeletal organization, which provide both
the protrusive and contractile forces necessary for cell migration
[24
, 26
, 27
,
42
43
44
]. Our results show that blockade of VCAM-1 but not
ICAM-1 reduced the number of monocytes migrating along the endothelium.
It is interesting that ICAM-1 blockade had an inhibitory effect on the
number of monocytes migrating but only when VCAM-1 was simultaneously
blocked. In addition, blockade of ICAM-1, VCAM-1, and both adhesion
molecules together reduced, to the same degree, the distance that
monocytes traveled. Therefore, it appears that independent mechanisms
regulate which monocytes respond by migrating and to what extent
migration proceeds.
Monocyte diapedesis
Our results showed that the blockade of either ICAM-1 or VCAM-1
has no significant effect on the number of THP-1 cells that
transmigrate through the endothelial monolayer. However, the
simultaneous blockade of both ICAM-1 and VCAM-1 resulted in a
significant reduction in THP-1 cell and PBM diapedesis. Perhaps
ICAM-1/LFA-1 interactions alone are able to initiate the cytoskeletal
rearrangements sufficient to allow monocytes to migrate through the
endothelium when VCAM-1 is blocked. During ICAM-1 blockade, the
opposite may be true. This compensatory ability to support diapedesis
might be caused by shared downstream signaling events involving members
of the Rho family of GTPases. It has been suggested that ICAM-1 and
VCAM-1 activations are transient and that this may affect the kinetics
of diapedesis [31
]. Lateral migration may require
specific cytoskeletal rearrangements initiated by a specific ratio of
inactive and active forms of Rho, Rac, and Cdc42. This ratio might
exist for only a short period, until the avidity of ICAM-1 and VCAM-1
for their respective ligands changes. A change in avidity could affect
the ratio of active and inactive Rho family members, resulting in the
formation of appropriate pseudopodial extensions through intercellular
junctions.
The observed involvement of VCAM-1 in transendothelial migration is not
in agreement with previous reports [31
] that show that
monocyte migration through human umbilical-vein EC monolayers on
polycarbonate membranes is independent of VCAM-1. One possibility for
this discrepancy could be the different types of ECs analyzed.
Differences in the expression of certain cell adhesion molecules within
different EC populations have been reported in studies comparing the
expression levels of these molecules in human arterial and venous ECs.
For example, cell-type-specific differences in VCAM-1 expression and
regulation by cytokines have been observed [45
,
46
]. The differential expression of these cell adhesion
molecules might therefore be functionally correlated, not only to the
number of monocytes transmigrating at particular vascular sites but
also to the different mechanisms that may regulate diapedesis.
Taken together, we demonstrated that blocking ICAM-1, VCAM-1, or both
adhesion molecules on ECs prevents the formation of pseudopodia and
lamellipodia by monocytes spreading on the monolayer. This blockade
reduced the ability of monocytes to migrate along the endothelium.
Therefore, a correlation appears to exist between the types of
protrusions monocytes make while spreading on top of ECs and the rate
at which they migrate along the monolayer. It also appears that the
morphological changes necessary for lateral migration are different
from those for transendothelial migration, but both are regulated in
part by ICAM-1/LFA-1 and VCAM-1/VLA-4 interactions.
Based on the results of our study, we propose that during monocyte
diapedesis, ICAM-1/LFA-1 and VCAM-1/VLA-4 interactions differentially
modulate the ratio between active and inactive forms of Rho, Rac, and
Cdc42. Future studies should aim at dissecting the precise roles of
these GTPases in linking ICAM-1- and VCAM-1-mediated adhesion to
changes in monocyte motility.
 |
ACKNOWLEDGEMENTS
|
|---|
J. Ronald and V. Ionescu were supported by studentships from the
government of Ontario. M. Sandig is a Heart and Stroke Foundation of
Ontario Scholar. This work was supported by the Heart and Stroke
Foundation of Ontario, grant T3723. We thank Ms. Nicole Bechard for
help with imaging. The THP-1 cells were a gift from Dr. M. Huff, The
Robarts Research Institute, London, ON. J. Ronald and C. Ionescu
contributed equally to this work.
Received December 7, 2000;
revised April 25, 2001;
accepted April 26, 2001.
 |
REFERENCES
|
|---|
-
Chia, M. C. (1998) The role of adhesion molecules in atherosclerosis Crit. Rev. Clin. Lab. Sci. 35,573-602[Medline]
-
Back, M. R., Carew, T. E., Schmidschoenbein, G. W. (1995) Deposition pattern of monocytes and fatty streak development in hypercholesterolemic rabbits Atherosclerosis 116,103-115[Medline]
-
Joris, I., Zand, T., Nunnari, J. J., Krolikowski, F. J., Majno, G. (1983) Studies on the pathogenesis of atherosclerosis. I. Adhesion and emigration of mononuclear cells in the aorta of hypercholesterolemic rats Am. J. Pathol. 113,341-358[Abstract]
-
Scalia, R., Appel, J. Z., Lefer, A. M. (1998) Leukocyte-endothelium interaction during the early stages of hypercholesterolemia in the rabbit: role of P-selectin, ICAM-1, and VCAM-1 Arterioscler. Thromb. Biol. 18,1093-1100[Abstract/Free Full Text]
-
Cotran, R. S., Mayadasnorton, T. (1998) Endothelium, leukocytes, and adhesion: endothelial adhesion molecules in health and disease Pathol. Biol. 46,164-170[Medline]
-
Dosquet, C., Wautier, J. L. (1992) Blood monocyte adhesion to vascular endothelial cellsimplication in vascular pathology Clin. Hemorheol. 12,817-829
-
Navab, M., Hama, S. Y., Nguyen, T. B., Fogelman, A. M. (1994) Monocyte adhesion and transmigration in atherosclerosis Cor. Art. Dis. 5,198-204
-
Masinovsky, B., Urdal, D., Gallatin, W. M. (1990) IL-4 acts synergistically with IL-1 beta to promote lymphocyte adhesion to microvascular endothelium by induction of vascular cell adhesion molecule-1 J. Immunol. 145,2886-2895[Abstract]
-
Meerschaert, J., Furie, M. B. (1995) The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium J. Immunol. 154,4099-4112[Abstract]
-
Shang, X. Z., Issekutz, A. C. (1998) Contribution of CD11A/CD18, CD11B/CD18, ICAM-1 (CD54) and -2 (CD102) to human monocyte migration through endothelium and connective tissue fibroblast barriers Eur. J. Immunol. 28,1970-1979[Medline]
-
OBrien, K. D., McDonald, T. O., Chait, A., Allen, M. D., Alpers, C. E. (1996) Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content Circulation 93,672-682[Abstract/Free Full Text]
-
Butcher, E. C. (1991) Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity Cell 67,1033-1036[Medline]
-
Luscinskas, F. W., Kansas, G. S., Ding, H., Pizcueta, P., Schleiffenbaum, B. E., Tedder, T. F., Gimbrone, M. A., Jr (1994) Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins J. Cell. Biol. 125,1417-1427[Abstract/Free Full Text]
-
Springer, T. A. (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76,301-314[Medline]
-
Adams, D. H., Shaw, S. (1994) Leucocyte-endothelial interactions and regulation of leucocyte migration Lancet 343,831-836[Medline]
-
Dedhar, S. (1999) Integrins and signal transduction Curr. Opin. Hematol. 6,37-43[Medline]
-
Ebnet, K., Kaldjian, E. P., Anderson, A. O., Shaw, S. (1996) Orchestrated information transfer underlying leukocyte endothelial interactions Annu. Rev. Immunol. 14,155-177[Medline]
-
Gahmberg, C. G. (1997) Leukocyte adhesion: CD11/CD18 integrins and intercellular adhesion molecules Curr. Opin. Cell Biol. 9,643-650[Medline]
-
Weber, K. S. C., Klickstein, L. B., Weber, C. (1999) Specific activation of leukocyte beta 2 integrins lymphocyte function-associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the alpha subunit cytoplasmic domains Mol. Biol. Cell 10,861-873[Abstract/Free Full Text]
-
Beekhuizen, H., van Furth, R. (1993) Monocyte adherence to human vascular endothelium J. Leukoc. Biol. 54,363-378[Abstract]
-
Bevilacqua, M. P., Nelson, R. M. (1993) Endothelial-leukocyte adhesion molecules in inflammation and metastasis Thromb. Haemos. 70,152-154[Medline]
-
Hakkert, B. C., Kuijpers, T. W., Leeuwenberg, J. F., van Mourik, J. A., Roos, D. (1991) Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD18, ELAM-1, and VLA-4 Blood 78,2721-2726[Abstract/Free Full Text]
-
Pettit, E. J., Fay, F. S. (1998) Cytosolic free calcium and the cytoskeleton in the control of leukocyte chemotaxis Physiol. Rev. 78,949-967[Abstract/Free Full Text]
-
Narumiya, S. (1996) The small GTPase Rho: cellular functions and signal transduction J. Biochem. 120,215-228[Abstract/Free Full Text]
-
Nobes, C. D., Hall, A. (1995) Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia Cell 81,53-62[Medline]
-
Allen, W. E., Jones, G. E., Pollard, J. W., Ridley, A. J. (1997) Rho, Rac and Cdc42 regulate actin organization and cell adhesion in macrophages J. Cell Sci. 110,707-720[Abstract]
-
Allen, W. E., Zicha, D., Ridley, A. J., Jones, G. E. (1998) A role for CDC42 in macrophage chemotaxis J. Cell Biol. 141,1147-1157[Abstract/Free Full Text]
-
Burridge, K., Chrzanowska-Wodnicka, M. (1996) Focal adhesions, contractility, and signaling Annu. Rev. Cell Dev. Biol. 12,463-518[Medline]
-
Beekhuizen, H., Corsel-Van Tilburg, A. J., Blokland, I., van Furth, R. (1991) Characterization of the adherence of human monocytes to cytokine-stimulated human macrovascular endothelial cells Immunology 74,661-669[Medline]
-
Beekhuizen, H., Verdegaal, E. M., Blokland, I., van Furth, R. (1992) Contribution of ICAM-1 and VCAM-1 to the morphological changes in monocytes bound to human venous endothelial cells stimulated with recombinant interleukin-4 (rIL-4) or rIL-1 alpha Immunology 77,469-472[Medline]
-
Weber, C., Springer, T. A. (1998) Interaction of very late antigen-4 with VCAM-1 supports transendothelial chemotaxis of monocytes by facilitating lateral migration J. Immunol. 161,6825-6834[Abstract/Free Full Text]
-
Weerasinghe, D., Mchugh, K. P., Ross, F. P., Brown, E. J., Gisler, R. H., Imhof, B. A. (1998) A role for the alpha-V-beta-3 integrin in the transmigration of monocytes J. Cell Biol. 142,595-607[Abstract/Free Full Text]
-
Porter, J. C., Hogg, N. (1997) Integrin cross talk: activation of lymphocyte function-associated antigen-1 on human T cells alters alpha4beta1- and alpha5beta1-mediated function J. Cell Biol. 138,1437-1447[Abstract/Free Full Text]
-
Sandig, M., Korvemaker, M. L., Ionescu, C. V., Negrou, E., Rogers, K. A. (1999) Transendothelial migration of monocytes in rat aorta: distribution of F-actin, alpha-catnin, LFA-1, and PECAM-1 Biotech. Histochem. 74,276-293[Medline]
-
Sandig, M., Negrou, E., Rogers, K. A. (1997) Changes in the distribution of LFA-1, catenins and F-actin during transendothelial migraton of monocytes in culture J. Cell Sci. 110,2807-2818[Abstract]
-
Graziani-Bowering, G. M., Graham, J. M., Filion, L. G. (1997) A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes J. Immunol. Methods 207,157-168[Medline]
-
Simmons, D., Makgoba, M. W., Seed, B. (1988) ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM Nature 331,624-627[Medline]
-
Dittel, B. N., McCarthy, J. B., Wayner, E. A., LeBien, T. W. (1993) Regulation of human B-cell precursor adhesion to bone marrow stromal cells by cytokines that exert opposing effects on the expression of vascular cell adhesion molecule-1 (VCAM-1) Blood 81,2272-2282[Abstract/Free Full Text]
-
Springer, T. A. (1990) Adhesion receptors of the immune system Nature 346,425-434[Medline]
-
Zar, Z. H. (1974) Biostatistical Analysis Prentice-Hall Englewood Cliffs, NJ.
-
Tapon, N., Hall, A. (1997) Rho, Rac and Cdc42 GTPases regulate the organization of the actin cytoskeleton Curr. Opin. Cell Biol. 9,86-92[Medline]
-
Aepfelbacher, M. (1995) ADP-ribosylation of Rho enhances adhesion of U937 cells to fibronectin via the alpha 5 beta 1 integrin receptor FEBS Lett 363,78-80[Medline]
-
Dharmawardhane, S., Bokoch, G. M. (1997) Rho GTPases and leukocyte cytoskeletal regulation Curr. Opin. Hematol. 4,12-18[Medline]
-
Laudanna, C., Campbell, J. J., Butcher, E. C. (1996) Role of Rho in chemoattractant-activated leukocyte adhesion through integrins Science 271,981-983[Abstract]
-
Hauser, I. A., Johnson, D. R., Madri, J. A. (1993) Differential induction of VCAM-1 on human iliac venous and arterial endothelial cells and its role in adhesion J. Immunol. 151,5172-5185[Abstract]
-
Kalogeris, T. J., Kevil, C. G., Laroux, F. S., Coe, L. L., Phifer, T. J., Alexander, J. S. (1999) Differential monocyte adhesion and adhesion molecule expression in venous and arterial endothelial cells Am. J. Physiol. 20,L9-L19
This article has been cited by other articles:

|
 |

|
 |
 
G. L. Bentz, M. Jarquin-Pardo, G. Chan, M. S. Smith, C. Sinzger, and A. D. Yurochko
Human Cytomegalovirus (HCMV) Infection of Endothelial Cells Promotes Naive Monocyte Extravasation and Transfer of Productive Virus To Enhance Hematogenous Dissemination of HCMV
J. Virol.,
December 1, 2006;
80(23):
11539 - 11555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Celli, J.-J. Ryckewaert, E. Delachanal, and A. Duperray
Evidence of a Functional Role for Interaction between ICAM-1 and Nonmuscle {alpha}-Actinins in Leukocyte Diapedesis
J. Immunol.,
September 15, 2006;
177(6):
4113 - 4121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-P. Chuang, Y.-F. Huang, Y.-L. Hsu, H.-S. Liu, H.-C. Chen, and C.-C. Shieh
Ligation of lymphocyte function-associated antigen-1 on monocytes decreases very late antigen-4-mediated adhesion through a reactive oxygen species-dependent pathway
Blood,
December 15, 2004;
104(13):
4046 - 4053.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. E.R. Kartikasari, N. A. Georgiou, F. L.J. Visseren, H. van Kats-Renaud, B. S. van Asbeck, and J. J.M. Marx
Intracellular Labile Iron Modulates Adhesion of Human Monocytes to Human Endothelial Cells
Arterioscler. Thromb. Vasc. Biol.,
December 1, 2004;
24(12):
2257 - 2262.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Smith, G. L. Bentz, P. M. Smith, E. R. Bivins, and A. D. Yurochko
HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner
J. Leukoc. Biol.,
July 1, 2004;
76(1):
65 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Wagner, B. Guldenzoph, B. Lienenluke, and M. Hecker
CD154/CD40-Mediated Expression of CD154 in Endothelial Cells: Consequences for Endothelial Cell-Monocyte Interaction
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2004;
24(4):
715 - 720.
[Abstract]
[Full Text]
[PDF]
|
 |
|